BARICITINIB, AN ORAL REVERSIBLE JANUS KINASE-1 AND-2 INHIBITOR, FOR ATOPIC DERMATITIS: HEAD AND NECK RESPONSE FROM BREEZE-AD4 AND BREEZE-AD7
ACTA DERMATO-VENEREOLOGICA(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ACTA DERMATO-VENEREOLOGICA(2022)